To this end, we first investigated if FOXO3 is recruited to PERK promoter in a previously published FOXO3 chromatin immunoprecipitation (ChIP)-Seq study in DLD1 colon carcinoma cells [26]. This evidence concerns the gene FOXO3 and colon carcinoma.